PrEP adherence among trans women in Brazil-access needed for this key population - Authors' reply

Lancet HIV. 2016 May;3(5):e200-1. doi: 10.1016/S2352-3018(16)30023-6.

Authors

Jae Sevelius¹, Madeline B Deutsch¹, David V Glidden¹, Robert M Grant²

Affiliations

¹ University of California, San Francisco, CA, USA.
² University of California, San Francisco, CA, USA; Gladstone Institutes and San Francisco AIDS Foundation, CA, USA. Electronic address: [email protected].

PMID: 27126486
DOI: 10.1016/S2352-3018(16)30023-6

No abstract available

Publication types

Letter
Comment

MeSH terms

Anti-HIV Agents
Brazil
Female
HIV Infections*
Humans
Medication Adherence
Pre-Exposure Prophylaxis*

Substances

Anti-HIV Agents